Welcome to the latest edition of the VINEx Grapevine.
If you have any feedback or would like to share any publications or articles we may have missed, please send them to: email@example.com
If you wish to opt out, simply click on the “unsubscribe” button.
Global Director - VINEx
Bienvenue à la dernière édition de "La vigne" de VINEx.
Si vous avez des commentaires, ou si vous souhaitez nous faire part de publications ou d'articles qui nous ont échappée, veuillez les envoyer par courriel à : firstname.lastname@example.org
Si vous souhaitez vous désabonner, il vous suffit de cliquer sur le bouton "désabonnement".
Directrice mondiale - VINEx
VINEx in the news
VINEx joined Senator Stanley Kutcher, scientists, relevant experts, and long-haulers in calling for urgent action on Long COVID in Canada. The call-to-action asks the federal government to demonstrate leadership by committing $100M over three years, to develop and deliver a robust, comprehensive and equitable pan-Canadian Long COVID strategy. We invite all Canadian to join this call to action.
Read coverage in the Halifax Examiner, Burnaby Now, and listen to an interview on CBC's White Coat, Black Art, with Susie Goulding, Founder of COVID Long Haulers Support Group Canada and contributor to the Long COVID Action Plan.
COVID-19 and the brain
Study by researchers at Western University showed significant cognitive impairment in patients with confirmed cases of COVID-19. View the results published in Cell Reports Medicine. Read more about the findings in Western News. Co-Author Dr. Adrian Owen, is a member of VINEx's Science Advisory Council.
Dr. Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, authored an opinion piece in The Guardian about the huge impact Long COVID is having on individuals, the healthcare system, and the workforce. He calls for sustained research investment into this condition including more data from low and middle-income countries. Read the rest of The Guardian Series "Living with Long COVID"
Nature Medicine - Long-term neurologic outcomes of COVID-19. This Research Briefing elaborates on the findings from a September 22, 2022 publication. The study showed that individuals who have had a SARS-CoV-2 infection are at increased risk for some neurological disorders, in comparison to people who were uninfected. The authors conclude "our report provides a comprehensive account of the neurological consequences of COVID-19 at one year after infection, and shows the substantial risks and burdens of a wide range of incident neurological disorders." Read more coverage of this study in Fortune.
The 2022 Global Report of the Lancet Countdown was published on October 26, 2022. The report examines the relationship between health and climate change across key domains and indicators. The authors note that "....the changing climate is affecting the spread of infectious diseases, putting populations at higher risk of emerging diseases and co-epidemics".
Evidence builds of viruses’ role in Alzheimer’s disease
An article in the Financial Times looks at current and past research into the links between viruses and Alzheimer's disease and other neurological disorders, including Professor Ruth Itzhaki's studies over the past 30 years examining the possible role of herpes virus HSV-1 in the development of Alzheimer’s disease.
The World Bank has released a report titled "Putting Pandemics Behind Us : Investing in One Health to Reduce Risks of Emerging Infectious Diseases". The report provides an investment framework for governments, international organizations and donors. It also makes the economic case for investing in prevention instead of responding and managing pandemics. Download the report.